# University of Texas Southwestern Medical Center: Phase 2 study completed, 120 enrolled (Substance Use Disorders, Substance Use)

**Score:** 80/100

| Field | Value |
|---|---|
| Sponsor | University of Texas Southwestern Medical Center |
| Sponsor type | Academic and hospital |
| Study | Ketamine for Methamphetamine Use Disorder |
| NCT ID | NCT06496750 |
| Phase | Phase 2 |
| Status | completed |
| Conditions | Substance Use Disorders; Substance Use; Methamphetamine Abuse |
| Intervention types | drug |
| Target enrollment | 120 |
| Site countries | United States |
| Posted | 2024-07-11 |
| Planned start | 2024-09-11 |
| Event | Completed |
| Event date | 2026-10-15 |
| Last update posted | 2026-10-27 |

## Why this score
- Posted in the last two weeks.
- Completed: closeout, analysis and the next study ahead.
- Phase 2: multi-site, larger budget.
- 120 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT06496750). Last refreshed: 2026-11-05T08:46:16.625Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.